Article Sidebar

PDF (Tiếng Việt)
Published: 2024-10-30
Abstract Views: 9
Views PDF (Tiếng Việt): 38
DOI: https://doi.org/10.52163/yhc.v65i6.1695
Issue
Vol. 65 No. 6
Section
Articles
How to Cite
Huyền, N. T., Ngọc, T. N., Vân, N. T., Huyền, N. T., & Anh, H. L. (2024). 40. PSYCHOLOGICAL DISORDERS IN PATIENTS WITH MALIGNANT BLOOD DISEASE AT THE BLOOD TRANSFUSION HEMATOLOGY CENTER, BACH MAI HOSPITAL IN 2024. Vietnam Journal of Community Medicine, 65(6). https://doi.org/10.52163/yhc.v65i6.1695

40. PSYCHOLOGICAL DISORDERS IN PATIENTS WITH MALIGNANT BLOOD DISEASE AT THE BLOOD TRANSFUSION HEMATOLOGY CENTER, BACH MAI HOSPITAL IN 2024

Nguyen Thi Huyen1,2, Tran Nguyen Ngoc2, Nguyen Thi Van2, Nguyen Thi Huyen2, Hoang Lan Anh2
1 Thang Long University
2 Bach Mai Hospital

Main Article Content

Abstract

Objective: Describe the current state of anxiety, depression, and stress in patients with malignant blood diseases at the Hematology and Blood Transfusion Center of Bach Mai Hospital in 2024.


Subjects and methods of research: A cross-sectional descriptive study was conducted on 390 patients at the Hematology and Blood Transfusion Center of Bach Mai Hospital from February 2024 to August 2024.


Results: The proportion of patients in the study with anxiety disorders, depression, and stress was 46.2%, 38.5%, and 22.8%, respectively.


Conclusions: The results showed that the rate of anxiety disorders, depression, and stress in patients was relatively high. Patients should be closely monitored for clinical symptoms and supported with palliative treatment.

Article Details

Keywords

Psychological disorders, malignant blood diseases, anxiety, depression, stress

References

[1] Hussain Y, Abdullah, Alsharif KF et al, Therapeutic Role of Carotenoids in Blood Cancer: Mechanistic Insights and Therapeutic Potential, Nutrients, 2022, 14(9).
[2] Mitchell AJ, Chan M, Bhatti H et al, Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies, Lancet Oncol, 2011, 12(2), pp. 160-74.
[3] Bortolato B, Hyphantis TN, Valpione S et al 7, Depression in cancer: The many biobehavioral pathways driving tumor progression, Cancer Treat Rev, 201, 52, pp. 58-70.
[4] WHO, Mental disorders, https://www.who.int/news-room/fact-sheets/detail/mental-disorders#:~:text=A%20mental%20disorder%20is%20characterized,different%20types%20of%20mental%20disorders.
[5] WHO, Stress, https://www.who.int/news-room/questions-and-answers/item/stress#:~:text=Stress%20can%20be%20defined%20as,experiences%20stress%20to%20some%20degree.
[6] Wang Y, Zou L, Jiang M et al, Measurement of distress in Chinese inpatients with lymphoma, Psychooncology, 2013, 22(7), pp. 1581-6.
[7] Posluszny DM, Bovbjerg DH, Syrjala KL et al, Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies, Support Care Cancer, 2019, 27(2), pp. 591-600.
[8] Oberoi D, White V, Seymour J et al, The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period, J Cancer Surviv, 2017, 11(3), pp. 329-338.
[9] Vargas-Román K, Díaz-Rodríguez CL, Cañadas-De la Fuente GA et al, Anxiety prevalence in lymphoma: A systematic review and meta-analysis, Health Psychol, 2020, 39(7), pp. 580-588.
[10] WHO, Depressive disorder (depression), https://www.who.int/news-room/fact-sheets/detail/depression.
[11] Hosaka T, Aoki T, Ichikawa Y, Emotional states of patients with hematological malignancies: preliminary study, Jpn J Clin Oncol, 1994, 24(4), pp. 186-90.
[12] Shi H, Ren H, Tian Y et al, Pain as a risk factor of depression and anxiety symptoms with multiple myeloma during maintenance therapy, Front Psychol, 2022, 13, pp. 1015497.